![Seong-Jin Kim](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Seong-Jin Kim
Amministratore Delegato presso
MEDPACTO, INC.
Patrimonio netto: 6 M $ in data 30/09/2026
Profilo
Seong-Jin Kim is the founder of MedPacto, Inc. (2013) as Chief Executive Officer, Director & CTO.
Dr. Kim is the founder of Celloram, Inc. (2018) as Director.
Dr. Kim is currently the Head-Cancer Institute at CHA University.
Formerly, Dr. Kim served as Independent Director, Head-Research & Development at THERAGEN ETEX Co., Ltd. Education includes a doctorate from the University of Tsukuba.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
MEDPACTO, INC. 6,36% | 30/06/2026 | 2.181.216 ( 6,36% ) | 5 M $ | 30/09/2026 |
| 15/03/2025 | 1.059.025 ( 2,85% ) | 2 M $ | 30/09/2026 |
Posizioni attive di Seong-Jin Kim
| Società | Posizione | Inizio |
|---|---|---|
| MEDPACTO, INC. | Amministratore Delegato | 19/06/2013 |
CHA University
 CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/07/2011 |
Celloram, Inc.
 Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Fondatore | 01/01/2018 |
Precedenti posizioni note di Seong-Jin Kim
| Società | Posizione | Fine |
|---|---|---|
| THERAGEN ETEX CO.,LTD. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Seong-Jin Kim
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
18
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Tsukuba
 University of Tsukuba Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
THERAGEN ETEX Co., Ltd.
 THERAGEN ETEX Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
CHA University
CHA University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MedPacto, Inc.
 MedPacto, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops anti-cancer drugs | Health Technology |
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Develops cellular immunotherapies to fight against cancer and metabolic disorders | Health Technology |
